Microplastics are chemically active, and could cause biological harm
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Oct-2026 03:16 ET (21-Oct-2026 07:16 GMT/UTC)
A new study found that when microplastics contact water, their surfaces can become chemically reactive; it could be how they get us sick.
SUNY Polytechnic Institute Assistant Professor of Accounting Dr. Katie Matt, collaborating with Daniel Hebert of Syracuse University, has published new research examining fraud in the federal Paycheck Protection Program (PPP), a key COVID-19 relief initiative for small businesses. Using publicly prosecuted fraud cases, the researchers found that limited oversight and verification procedures enabled widespread abuse, including the use of falsified financial records, fictitious businesses, and weak application screening processes. The research underscores the challenge of balancing the rapid distribution of emergency aid with accountability safeguards that protect taxpayer resources and ensure assistance reaches intended recipients. Their findings offer practical recommendations for policymakers designing future disaster and economic relief programs.
Hebrew SeniorLife’s Right Care, Right Place, Right Time (R3) has a new name — Health Allies.
Health Allies brings healthy aging teams into affordable senior housing communities to help older adults navigate the health care system, optimize their health and well-being, remain independent longer, and enjoy their best possible lives. It is currently in place at 18 affordable housing communities across Greater Boston.
Rima Kaddurah-Daouk, PhD, professor and chair in the Department of Precision Behavioral Health at UTHealth Houston School of Behavioral Health Sciences, has secured a five-year, $12 million grant from the National Institute on Aging to investigate how changes in the brain’s energy supply affect memory, mood, and Alzheimer’s disease risk, and explore treatments and lifestyle strategies that could help people maintain brain health as they age.
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer’s disease, helping clinicians visualise the biological changes associated with the condition and guide decisions about new therapies. Amyloid PET imaging is being used to confirm the presence of amyloid pathology and support treatment decisions for patients receiving anti-amyloid drugs, while tau PET scans can provide additional information about disease progression and prognosis. At the 39th Annual Congress of the European Association of Nuclear Medicine (EANM’26), taking place from 17 to 21 October in Vienna, experts will discuss first experiences with these PET scans in routine clinical use and explore the latest advances in nuclear medicine.